Markets · Global Equities · US

Acrivon Therapeutics, Inc. ACRV

Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.

• Revenue TTM —
• EBITDA TTM -79.52M
• Net debt —
• ND/EBITDA —
• EBITDA/interest —
• ROE -0.88
• Implied band

All countries